Representatives of 22 scientific societies and entities in the health field have pointed out that the approach to chronicity, the incorporation of artificial intelligence (AI), the sustainability of the system, and effective data management are decisive elements for evolving towards a more proactive, predictive, and value-based healthcare.
These conclusions have been put on the table during the meeting "Leaders in Health," driven by the biopharmaceutical company Boehringer Ingelheim, with the aim of analyzing the major challenges and opportunities of the healthcare system and studying possible lines of action to improve the current model.
The participants have emphasized the transformative effect of digitalization and the ethical use of AI at all care levels. Likewise, they have stressed the need to move towards a model that recognizes the value of data and its proper governance, given its capacity to measure, manage, and anticipate clinical needs.
At the same time, they have defended the importance of placing the voice of patients at the core of the system, reinforcing collaboration with scientific societies and patient associations, so that their needs and experiences are effectively integrated into healthcare decision-making.
RESEARCH AND INNOVATION NETWORKS
During the debate, the commissioner of the PERTE for Cutting-Edge Health of the Ministry of Science, Innovation, and Universities, Raquel Yotti, has highlighted the role of scientific societies within national and international research and innovation networks, as well as the opportunities they provide to connect knowledge and capabilities, promote collaboration, and generate a greater impact on the healthcare system.
On the other hand, the general director of Boehringer Ingelheim Spain, Nicolas Dumoulin, has emphasized that scientific societies act as drivers of care excellence and has reiterated the importance of strengthening public-private collaboration.
"The solutions that our healthcare system needs require dialogue and the ability to build bridges between institutions, professionals, scientific societies, patients, administrations, and companies. And we have to do it because we all share the same purpose: to improve the health and lives of people," he pointed out.